{"entity":{"type":"insider","cik":"0001785299","url":"/insider/0001785299","json_url":"/insider/0001785299.json","name":"Loose Christopher R.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":63,"n_filings":35,"first":"2020-04-10","last":"2023-07-31","span_basis":"filed_date"},"name_variants":[{"name":"Loose Christopher R.","source":"filing","n_filings":35,"first_seen":"2020-04-10","last_seen":"2023-07-31"}],"transactions":[{"id":8121165,"accession":"0001127602-23-021561","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-021561","line_url":"/filing/0001127602-23-021561#line-2","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785299","owner_name":"Loose Christopher R.","owner_display_name":"Loose Christopher R.","owner_url":"/insider/0001785299","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1344.0,"shares_display":"1,344","price_per_share":0.46,"price_display":"0.46","price_state":"stated","total_value":618.24,"total_display":"618.24","total_whole":"618","shares_owned_after":183650.0,"shares_owned_after_display":"183,650","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-28","filed_date":"2023-07-31","scope":"insider"},{"id":8121162,"accession":"0001127602-23-021561","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-23-021561","line_url":"/filing/0001127602-23-021561#line-1","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785299","owner_name":"Loose Christopher R.","owner_display_name":"Loose Christopher R.","owner_url":"/insider/0001785299","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1373.0,"shares_display":"1,373","price_per_share":0.53,"price_display":"0.53","price_state":"stated","total_value":727.69,"total_display":"727.69","total_whole":"728","shares_owned_after":184994.0,"shares_owned_after_display":"184,994","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-27","filed_date":"2023-07-31","scope":"insider"},{"id":8530340,"accession":"0000950170-23-035163","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-23-035163","line_url":"/filing/0000950170-23-035163#line-2","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785299","owner_name":"Loose Christopher R.","owner_display_name":"Loose Christopher R.","owner_url":"/insider/0001785299","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1329.0,"shares_display":"1,329","price_per_share":0.51,"price_display":"0.51","price_state":"stated","total_value":677.79,"total_display":"677.79","total_whole":"678","shares_owned_after":186367.0,"shares_owned_after_display":"186,367","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-26","filed_date":"2023-07-27","scope":"insider"},{"id":8530337,"accession":"0000950170-23-035163","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-035163","line_url":"/filing/0000950170-23-035163#line-1","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785299","owner_name":"Loose Christopher R.","owner_display_name":"Loose Christopher R.","owner_url":"/insider/0001785299","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1390.0,"shares_display":"1,390","price_per_share":0.5,"price_display":"0.50","price_state":"stated","total_value":695.0,"total_display":"695.00","total_whole":"695","shares_owned_after":187696.0,"shares_owned_after_display":"187,696","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-25","filed_date":"2023-07-27","scope":"insider"},{"id":8250830,"accession":"0000950170-23-034475","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-23-034475","line_url":"/filing/0000950170-23-034475#line-2","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785299","owner_name":"Loose Christopher R.","owner_display_name":"Loose Christopher R.","owner_url":"/insider/0001785299","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1438.0,"shares_display":"1,438","price_per_share":0.54,"price_display":"0.54","price_state":"stated","total_value":776.52,"total_display":"776.52","total_whole":"777","shares_owned_after":189086.0,"shares_owned_after_display":"189,086","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-24","filed_date":"2023-07-25","scope":"insider"},{"id":8250827,"accession":"0000950170-23-034475","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-034475","line_url":"/filing/0000950170-23-034475#line-1","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785299","owner_name":"Loose Christopher R.","owner_display_name":"Loose Christopher R.","owner_url":"/insider/0001785299","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1333.0,"shares_display":"1,333","price_per_share":0.61,"price_display":"0.61","price_state":"stated","total_value":813.13,"total_display":"813.13","total_whole":"813","shares_owned_after":190524.0,"shares_owned_after_display":"190,524","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-21","filed_date":"2023-07-25","scope":"insider"},{"id":8675437,"accession":"0001127602-23-021133","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-021133","line_url":"/filing/0001127602-23-021133#line-2","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785299","owner_name":"Loose Christopher R.","owner_display_name":"Loose Christopher R.","owner_url":"/insider/0001785299","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1361.0,"shares_display":"1,361","price_per_share":0.64,"price_display":"0.64","price_state":"stated","total_value":871.04,"total_display":"871.04","total_whole":"871","shares_owned_after":191857.0,"shares_owned_after_display":"191,857","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-20","filed_date":"2023-07-21","scope":"insider"},{"id":8675434,"accession":"0001127602-23-021133","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-23-021133","line_url":"/filing/0001127602-23-021133#line-1","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785299","owner_name":"Loose Christopher R.","owner_display_name":"Loose Christopher R.","owner_url":"/insider/0001785299","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1335.0,"shares_display":"1,335","price_per_share":0.65,"price_display":"0.65","price_state":"stated","total_value":867.75,"total_display":"867.75","total_whole":"868","shares_owned_after":193218.0,"shares_owned_after_display":"193,218","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-19","filed_date":"2023-07-21","scope":"insider"},{"id":7845947,"accession":"0001127602-23-020997","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-020997","line_url":"/filing/0001127602-23-020997#line-2","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785299","owner_name":"Loose Christopher R.","owner_display_name":"Loose Christopher R.","owner_url":"/insider/0001785299","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1484.0,"shares_display":"1,484","price_per_share":0.56,"price_display":"0.56","price_state":"stated","total_value":831.04,"total_display":"831.04","total_whole":"831","shares_owned_after":194553.0,"shares_owned_after_display":"194,553","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-18","filed_date":"2023-07-19","scope":"insider"},{"id":7845944,"accession":"0001127602-23-020997","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-23-020997","line_url":"/filing/0001127602-23-020997#line-1","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785299","owner_name":"Loose Christopher R.","owner_display_name":"Loose Christopher R.","owner_url":"/insider/0001785299","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1415.0,"shares_display":"1,415","price_per_share":0.67,"price_display":"0.67","price_state":"stated","total_value":948.05,"total_display":"948.05","total_whole":"948","shares_owned_after":196037.0,"shares_owned_after_display":"196,037","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-17","filed_date":"2023-07-19","scope":"insider"},{"id":8625130,"accession":"0001127602-23-020819","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-020819","line_url":"/filing/0001127602-23-020819#line-2","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785299","owner_name":"Loose Christopher R.","owner_display_name":"Loose Christopher R.","owner_url":"/insider/0001785299","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":906.0,"shares_display":"906","price_per_share":0.59,"price_display":"0.59","price_state":"stated","total_value":534.54,"total_display":"534.54","total_whole":"535","shares_owned_after":197452.0,"shares_owned_after_display":"197,452","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-14","filed_date":"2023-07-17","scope":"insider"},{"id":8625126,"accession":"0001127602-23-020819","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-23-020819","line_url":"/filing/0001127602-23-020819#line-1","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785299","owner_name":"Loose Christopher R.","owner_display_name":"Loose Christopher R.","owner_url":"/insider/0001785299","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1329.0,"shares_display":"1,329","price_per_share":0.39,"price_display":"0.39","price_state":"stated","total_value":518.31,"total_display":"518.31","total_whole":"518","shares_owned_after":198358.0,"shares_owned_after_display":"198,358","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-13","filed_date":"2023-07-17","scope":"insider"},{"id":8121130,"accession":"0001127602-23-020671","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-020671","line_url":"/filing/0001127602-23-020671#line-2","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785299","owner_name":"Loose Christopher R.","owner_display_name":"Loose Christopher R.","owner_url":"/insider/0001785299","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1335.0,"shares_display":"1,335","price_per_share":0.39,"price_display":"0.39","price_state":"stated","total_value":520.65,"total_display":"520.65","total_whole":"521","shares_owned_after":199687.0,"shares_owned_after_display":"199,687","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-12","filed_date":"2023-07-13","scope":"insider"},{"id":8121124,"accession":"0001127602-23-020671","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-23-020671","line_url":"/filing/0001127602-23-020671#line-1","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785299","owner_name":"Loose Christopher R.","owner_display_name":"Loose Christopher R.","owner_url":"/insider/0001785299","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1363.0,"shares_display":"1,363","price_per_share":0.37,"price_display":"0.37","price_state":"stated","total_value":504.31,"total_display":"504.31","total_whole":"504","shares_owned_after":201022.0,"shares_owned_after_display":"201,022","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-11","filed_date":"2023-07-13","scope":"insider"},{"id":9212931,"accession":"0000950170-23-032734","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-23-032734","line_url":"/filing/0000950170-23-032734#line-2","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785299","owner_name":"Loose Christopher R.","owner_display_name":"Loose Christopher R.","owner_url":"/insider/0001785299","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1304.0,"shares_display":"1,304","price_per_share":0.37,"price_display":"0.37","price_state":"stated","total_value":482.48,"total_display":"482.48","total_whole":"482","shares_owned_after":202385.0,"shares_owned_after_display":"202,385","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-10","filed_date":"2023-07-12","scope":"insider"},{"id":8524583,"accession":"0001127602-23-020573","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001127602-23-020573","line_url":"/filing/0001127602-23-020573#line-4","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785299","owner_name":"Loose Christopher R.","owner_display_name":"Loose Christopher R.","owner_url":"/insider/0001785299","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1304.0,"shares_display":"1,304","price_per_share":0.37,"price_display":"0.37","price_state":"stated","total_value":482.48,"total_display":"482.48","total_whole":"482","shares_owned_after":66023.0,"shares_owned_after_display":"66,023","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-10","filed_date":"2023-07-11","scope":"insider"},{"id":9212932,"accession":"0000950170-23-032734","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-032734","line_url":"/filing/0000950170-23-032734#line-1","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785299","owner_name":"Loose Christopher R.","owner_display_name":"Loose Christopher R.","owner_url":"/insider/0001785299","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1306.0,"shares_display":"1,306","price_per_share":0.36,"price_display":"0.36","price_state":"stated","total_value":470.16,"total_display":"470.16","total_whole":"470","shares_owned_after":203689.0,"shares_owned_after_display":"203,689","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-07","filed_date":"2023-07-12","scope":"insider"},{"id":8524576,"accession":"0001127602-23-020573","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-020573","line_url":"/filing/0001127602-23-020573#line-2","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785299","owner_name":"Loose Christopher R.","owner_display_name":"Loose Christopher R.","owner_url":"/insider/0001785299","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1306.0,"shares_display":"1,306","price_per_share":0.36,"price_display":"0.36","price_state":"stated","total_value":470.16,"total_display":"470.16","total_whole":"470","shares_owned_after":62781.0,"shares_owned_after_display":"62,781","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-07","filed_date":"2023-07-11","scope":"insider"},{"id":9212928,"accession":"0000950170-23-032730","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-032730","line_url":"/filing/0000950170-23-032730#line-1","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785299","owner_name":"Loose Christopher R.","owner_display_name":"Loose Christopher R.","owner_url":"/insider/0001785299","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1384.0,"shares_display":"1,384","price_per_share":0.34,"price_display":"0.34","price_state":"stated","total_value":470.56,"total_display":"470.56","total_whole":"471","shares_owned_after":198666.0,"shares_owned_after_display":"198,666","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-06","filed_date":"2023-07-12","scope":"insider"},{"id":8699457,"accession":"0001127602-23-020471","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-23-020471","line_url":"/filing/0001127602-23-020471#line-3","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785299","owner_name":"Loose Christopher R.","owner_display_name":"Loose Christopher R.","owner_url":"/insider/0001785299","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1384.0,"shares_display":"1,384","price_per_share":0.34,"price_display":"0.34","price_state":"stated","total_value":470.56,"total_display":"470.56","total_whole":"471","shares_owned_after":57758.0,"shares_owned_after_display":"57,758","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-06","filed_date":"2023-07-07","scope":"insider"},{"id":6360985,"accession":"0001127602-22-019051","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-22-019051","line_url":"/filing/0001127602-22-019051#line-2","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785299","owner_name":"Loose Christopher R.","owner_display_name":"Loose Christopher R.","owner_url":"/insider/0001785299","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4415.0,"shares_display":"4,415","price_per_share":1.53,"price_display":"1.53","price_state":"stated","total_value":6754.95,"total_display":"6,754.95","total_whole":"6,755","shares_owned_after":50050.0,"shares_owned_after_display":"50,050","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-06","filed_date":"2022-07-07","scope":"insider"},{"id":6991765,"accession":"0001127602-22-006339","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-22-006339","line_url":"/filing/0001127602-22-006339#line-2","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785299","owner_name":"Loose Christopher R.","owner_display_name":"Loose Christopher R.","owner_url":"/insider/0001785299","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1069.0,"shares_display":"1,069","price_per_share":3.53,"price_display":"3.53","price_state":"stated","total_value":3773.57,"total_display":"3,773.57","total_whole":"3,774","shares_owned_after":34827.0,"shares_owned_after_display":"34,827","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-22","filed_date":"2022-02-23","scope":"insider"},{"id":6991762,"accession":"0001127602-22-006339","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-22-006339","line_url":"/filing/0001127602-22-006339#line-1","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785299","owner_name":"Loose Christopher R.","owner_display_name":"Loose Christopher R.","owner_url":"/insider/0001785299","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":974.0,"shares_display":"974","price_per_share":3.873,"price_display":"3.87","price_state":"stated","total_value":3772.302,"total_display":"3,772.30","total_whole":"3,772","shares_owned_after":35896.0,"shares_owned_after_display":"35,896","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-18","filed_date":"2022-02-23","scope":"insider"},{"id":6719234,"accession":"0001127602-22-005752","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-22-005752","line_url":"/filing/0001127602-22-005752#line-2","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785299","owner_name":"Loose Christopher R.","owner_display_name":"Loose Christopher R.","owner_url":"/insider/0001785299","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900.0,"shares_display":"900","price_per_share":4.193,"price_display":"4.19","price_state":"stated","total_value":3773.7,"total_display":"3,773.70","total_whole":"3,774","shares_owned_after":36870.0,"shares_owned_after_display":"36,870","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-17","filed_date":"2022-02-18","scope":"insider"},{"id":6719231,"accession":"0001127602-22-005752","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-22-005752","line_url":"/filing/0001127602-22-005752#line-1","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785299","owner_name":"Loose Christopher R.","owner_display_name":"Loose Christopher R.","owner_url":"/insider/0001785299","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":851.0,"shares_display":"851","price_per_share":4.429,"price_display":"4.43","price_state":"stated","total_value":3769.079,"total_display":"3,769.08","total_whole":"3,769","shares_owned_after":37770.0,"shares_owned_after_display":"37,770","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-16","filed_date":"2022-02-18","scope":"insider"},{"id":6637400,"accession":"0001127602-22-005331","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-22-005331","line_url":"/filing/0001127602-22-005331#line-2","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785299","owner_name":"Loose Christopher R.","owner_display_name":"Loose Christopher R.","owner_url":"/insider/0001785299","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":863.0,"shares_display":"863","price_per_share":4.331,"price_display":"4.33","price_state":"stated","total_value":3737.653,"total_display":"3,737.65","total_whole":"3,738","shares_owned_after":38621.0,"shares_owned_after_display":"38,621","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-15","filed_date":"2022-02-16","scope":"insider"},{"id":4515688,"accession":"0001127602-21-003789","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-21-003789","line_url":"/filing/0001127602-21-003789#line-2","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785299","owner_name":"Loose Christopher R.","owner_display_name":"Loose Christopher R.","owner_url":"/insider/0001785299","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":47.19,"price_display":"47.19","price_state":"stated","total_value":94380.0,"total_display":"94,380.00","total_whole":"94,380","shares_owned_after":21782.0,"shares_owned_after_display":"21,782","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-03","filed_date":"2021-02-03","scope":"insider"},{"id":4515686,"accession":"0001127602-21-003789","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-21-003789","line_url":"/filing/0001127602-21-003789#line-1","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785299","owner_name":"Loose Christopher R.","owner_display_name":"Loose Christopher R.","owner_url":"/insider/0001785299","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":45.0245,"price_display":"45.02","price_state":"stated","total_value":360196.0,"total_display":"360,196.00","total_whole":"360,196","shares_owned_after":23782.0,"shares_owned_after_display":"23,782","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-02","filed_date":"2021-02-03","scope":"insider"},{"id":5249456,"accession":"0001127602-21-002856","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-21-002856","line_url":"/filing/0001127602-21-002856#line-1","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785299","owner_name":"Loose Christopher R.","owner_display_name":"Loose Christopher R.","owner_url":"/insider/0001785299","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":42.5,"price_display":"42.50","price_state":"stated","total_value":340000.0,"total_display":"340,000.00","total_whole":"340,000","shares_owned_after":31782.0,"shares_owned_after_display":"31,782","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-27","filed_date":"2021-01-28","scope":"insider"},{"id":2353811,"accession":"0001127602-20-031890","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-20-031890","line_url":"/filing/0001127602-20-031890","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785299","owner_name":"Loose Christopher R.","owner_display_name":"Loose Christopher R.","owner_url":"/insider/0001785299","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":40.62515,"price_display":"40.63","price_state":"stated","total_value":325001.2,"total_display":"325,001.20","total_whole":"325,001","shares_owned_after":41782.0,"shares_owned_after_display":"41,782","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-17","filed_date":"2020-12-17","scope":"insider","n_lines":2},{"id":3138411,"accession":"0001127602-20-031578","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001127602-20-031578","line_url":"/filing/0001127602-20-031578","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785299","owner_name":"Loose Christopher R.","owner_display_name":"Loose Christopher R.","owner_url":"/insider/0001785299","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":38.935,"price_display":"38.94","price_state":"stated","total_value":311480.0,"total_display":"311,480.00","total_whole":"311,480","shares_owned_after":47782.0,"shares_owned_after_display":"47,782","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-16","filed_date":"2020-12-16","scope":"insider","n_lines":2},{"id":3138403,"accession":"0001127602-20-031578","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-20-031578","line_url":"/filing/0001127602-20-031578#line-2","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785299","owner_name":"Loose Christopher R.","owner_display_name":"Loose Christopher R.","owner_url":"/insider/0001785299","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":37.28,"price_display":"37.28","price_state":"stated","total_value":298240.0,"total_display":"298,240.00","total_whole":"298,240","shares_owned_after":55782.0,"shares_owned_after_display":"55,782","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-15","filed_date":"2020-12-16","scope":"insider"},{"id":3138397,"accession":"0001127602-20-031578","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-20-031578","line_url":"/filing/0001127602-20-031578#line-1","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785299","owner_name":"Loose Christopher R.","owner_display_name":"Loose Christopher R.","owner_url":"/insider/0001785299","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":35.0,"price_display":"35.00","price_state":"stated","total_value":280000.0,"total_display":"280,000.00","total_whole":"280,000","shares_owned_after":63782.0,"shares_owned_after_display":"63,782","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-14","filed_date":"2020-12-16","scope":"insider"},{"id":3051155,"accession":"0001127602-20-028483","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-20-028483","line_url":"/filing/0001127602-20-028483#line-2","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785299","owner_name":"Loose Christopher R.","owner_display_name":"Loose Christopher R.","owner_url":"/insider/0001785299","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":24.0,"price_display":"24.00","price_state":"stated","total_value":192000.0,"total_display":"192,000.00","total_whole":"192,000","shares_owned_after":71782.0,"shares_owned_after_display":"71,782","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-09","filed_date":"2020-11-09","scope":"insider"},{"id":3051146,"accession":"0001127602-20-028483","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-20-028483","line_url":"/filing/0001127602-20-028483#line-1","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785299","owner_name":"Loose Christopher R.","owner_display_name":"Loose Christopher R.","owner_url":"/insider/0001785299","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":23.0,"price_display":"23.00","price_state":"stated","total_value":184000.0,"total_display":"184,000.00","total_whole":"184,000","shares_owned_after":79782.0,"shares_owned_after_display":"79,782","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-05","filed_date":"2020-11-09","scope":"insider"},{"id":2925933,"accession":"0001127602-20-026930","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-20-026930","line_url":"/filing/0001127602-20-026930#line-1","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785299","owner_name":"Loose Christopher R.","owner_display_name":"Loose Christopher R.","owner_url":"/insider/0001785299","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":22.0,"price_display":"22.00","price_state":"stated","total_value":176000.0,"total_display":"176,000.00","total_whole":"176,000","shares_owned_after":87782.0,"shares_owned_after_display":"87,782","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-13","filed_date":"2020-10-14","scope":"insider"},{"id":2572730,"accession":"0001127602-20-026721","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-20-026721","line_url":"/filing/0001127602-20-026721#line-3","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785299","owner_name":"Loose Christopher R.","owner_display_name":"Loose Christopher R.","owner_url":"/insider/0001785299","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":21.12,"price_display":"21.12","price_state":"stated","total_value":168960.0,"total_display":"168,960.00","total_whole":"168,960","shares_owned_after":95782.0,"shares_owned_after_display":"95,782","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-08","filed_date":"2020-10-08","scope":"insider"},{"id":2572724,"accession":"0001127602-20-026721","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-20-026721","line_url":"/filing/0001127602-20-026721#line-2","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785299","owner_name":"Loose Christopher R.","owner_display_name":"Loose Christopher R.","owner_url":"/insider/0001785299","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":20.0013,"price_display":"20.00","price_state":"stated","total_value":160010.4,"total_display":"160,010.40","total_whole":"160,010","shares_owned_after":103782.0,"shares_owned_after_display":"103,782","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-07","filed_date":"2020-10-08","scope":"insider"},{"id":2572719,"accession":"0001127602-20-026721","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-20-026721","line_url":"/filing/0001127602-20-026721#line-1","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785299","owner_name":"Loose Christopher R.","owner_display_name":"Loose Christopher R.","owner_url":"/insider/0001785299","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":19.46,"price_display":"19.46","price_state":"stated","total_value":155680.0,"total_display":"155,680.00","total_whole":"155,680","shares_owned_after":111782.0,"shares_owned_after_display":"111,782","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-06","filed_date":"2020-10-08","scope":"insider"},{"id":3185164,"accession":"0001127602-20-026567","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-20-026567","line_url":"/filing/0001127602-20-026567#line-3","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785299","owner_name":"Loose Christopher R.","owner_display_name":"Loose Christopher R.","owner_url":"/insider/0001785299","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":18.35,"price_display":"18.35","price_state":"stated","total_value":146800.0,"total_display":"146,800.00","total_whole":"146,800","shares_owned_after":119782.0,"shares_owned_after_display":"119,782","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-05","filed_date":"2020-10-05","scope":"insider"},{"id":3185161,"accession":"0001127602-20-026567","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-20-026567","line_url":"/filing/0001127602-20-026567#line-2","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785299","owner_name":"Loose Christopher R.","owner_display_name":"Loose Christopher R.","owner_url":"/insider/0001785299","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":18.92,"price_display":"18.92","price_state":"stated","total_value":151360.0,"total_display":"151,360.00","total_whole":"151,360","shares_owned_after":127782.0,"shares_owned_after_display":"127,782","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-02","filed_date":"2020-10-05","scope":"insider"},{"id":3185158,"accession":"0001127602-20-026567","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-20-026567","line_url":"/filing/0001127602-20-026567#line-1","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785299","owner_name":"Loose Christopher R.","owner_display_name":"Loose Christopher R.","owner_url":"/insider/0001785299","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":18.84,"price_display":"18.84","price_state":"stated","total_value":150720.0,"total_display":"150,720.00","total_whole":"150,720","shares_owned_after":135782.0,"shares_owned_after_display":"135,782","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-01","filed_date":"2020-10-05","scope":"insider"},{"id":2108784,"accession":"0001127602-20-025709","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-20-025709","line_url":"/filing/0001127602-20-025709","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785299","owner_name":"Loose Christopher R.","owner_display_name":"Loose Christopher R.","owner_url":"/insider/0001785299","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4500.0,"shares_display":"4,500","price_per_share":21.132654,"price_display":"21.13","price_state":"stated","total_value":95096.943,"total_display":"95,096.94","total_whole":"95,097","shares_owned_after":143806.0,"shares_owned_after_display":"143,806","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-23","filed_date":"2020-09-25","scope":"insider","n_lines":3},{"id":2176789,"accession":"0001127602-20-024908","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-20-024908","line_url":"/filing/0001127602-20-024908","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785299","owner_name":"Loose Christopher R.","owner_display_name":"Loose Christopher R.","owner_url":"/insider/0001785299","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4500.0,"shares_display":"4,500","price_per_share":18.970852,"price_display":"18.97","price_state":"stated","total_value":85368.834,"total_display":"85,368.83","total_whole":"85,369","shares_owned_after":149058.0,"shares_owned_after_display":"149,058","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-09","filed_date":"2020-09-10","scope":"insider","n_lines":2},{"id":2258468,"accession":"0001127602-20-023991","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-20-023991","line_url":"/filing/0001127602-20-023991#line-1","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785299","owner_name":"Loose Christopher R.","owner_display_name":"Loose Christopher R.","owner_url":"/insider/0001785299","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4500.0,"shares_display":"4,500","price_per_share":22.9666,"price_display":"22.97","price_state":"stated","total_value":103349.7,"total_display":"103,349.70","total_whole":"103,350","shares_owned_after":152782.0,"shares_owned_after_display":"152,782","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-19","filed_date":"2020-08-20","scope":"insider"}],"collapsed":true,"next_cursor":"2020-08-19|2258468","ledger_fault":false,"count":{"value":63,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":63,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":63},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001703647","name":"Frequency Therapeutics, Inc.","url":"/issuer/0001703647","role":"Officer (Chief Scientific Officer)","n_filings":35,"first_seen":"2020-04-10","last_seen":"2023-07-31"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001785299","retrieved_at":"2026-08-25T10:35:58+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}